Has Shea Fleming received payments from drug or device companies?

Yes. Drug and device makers reported $2,586 in general payments to Shea Fleming across 70 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shea Fleming did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shea Fleming come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shea Fleming

Pediatrics · Atlanta, GANPI 1063585636

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.9%), consulting fees and other — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 48.3% of the total. Reporting peaked in 2021 at $1,521 and has fallen 84.2% since, to $240 in 2025. Among pediatrics clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,586in general payments, 2019–2025

Across 70 payments — averaging $36.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$1K
Sanofi-aventis U.S. LLC$208
Supernus Pharmaceuticals, Inc.$193
Tris Pharma Inc$169
Corium, LLC$113
Pfizer$86
plus $566 from 14 others

What the payments were for

Consulting fees$1,25048%
Food & beverage$1,31551%
Other$211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	2	$1,250
Sanofi-aventis U.S. LLC	8	$208
Supernus Pharmaceuticals, Inc.	8	$193
Tris Pharma Inc	11	$169
Corium, LLC	5	$113
Pfizer	4	$86
GSK	4	$69
Merck	5	$69
Kaleo, Inc.	4	$66
Biomarin Pharmaceutical Inc.	2	$53
Adlon Therapeutics L.p.	3	$49
Verrica Pharmaceuticals Inc.	2	$47
Cranial Technologies, Inc	2	$37
Seqirus USA Inc	2	$36
Baxter Healthcare	2	$33
Boston Scientific	2	$31
LNHC, Inc	1	$27
AstraZeneca	1	$21
Ironshore Pharmaceuticals Inc.	1	$15
Takeda Pharmaceuticals U.S.A., Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$1,250

How this compares

$2,586 in reported general payments places this provider in the 95th percentile of 2,111 pediatrics providers in Georgia.

See all pediatrics providers in Georgia →

Other pediatrics in Atlanta

Amir AshrafiAtlanta$563K
Satheesh ChonatAtlanta$147K
Karen ZimowskiAtlanta$139K
Iyabode Akinsanya-BeysolowAtlanta$103K
Lauren MiddlebrooksAtlanta$71K
Rebecca EmoryAtlanta$40K
Mark GriffithsAtlanta$34K
Kelly TickleAtlanta$29K
Robert WiskindAtlanta$21K
Mary BertossiAtlanta$20K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →